Articles

The journey from a promising biotech innovation to a commercially viable global product is one of the most complex paths in any industry. It demands not just scientific rigour, but a deep understanding of regulatory systems, market dynamics, and commercial strategy across multiple jurisdictions. Many promising assets never reach the patients or customers they were designed for - not because the science failed, but because the path to market was poorly planned...
 

The biotech industry has always been defined by its science. But increasingly, the companies that succeed commercially are distinguished not just by the quality of their products, but by how effectively they use digital tools to bring those products to market. From clinical development through to post-launch market management, digital capabilities are reshaping what is possible - and raising the bar for what is expected...